XML 13 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Revenues:    
Total revenues $ 5,045,000 $ 4,454,000
Operating expenses (income):    
Cost of revenues 2,963,000 2,174,000
Research and development 53,000 64,000
Gain on sale of intangible assets (4,000,000) 0
Gain on sale of property and equipment 0 (29,000)
Impairment of property and equipment 36,000 0
Impairment of ROU asset 0 113,000
Selling, general and administrative 9,641,000 8,234,000
Total operating expenses 8,693,000 10,556,000
Loss from operations (3,648,000) (6,102,000)
Interest income 782,000 695,000
Other income, net 31,000 48,000
Valuation loss on March 2023 PIPE 0 (6,076,000)
Change in fair value of common stock warrant and option liabilities (1,474,000) 6,544,000
Issuance and offering costs allocated to liability classified options 0 (430,000)
Net loss from continuing operations before income taxes (4,309,000) (5,321,000)
Income tax expense (8,000) (8,000)
Net loss from continuing operations (4,317,000) (5,329,000)
Net loss (7,038,000) (13,986,000)
Net loss attributable to non-controlling interest 0 (5,000)
Net loss attributable to common stockholders $ (7,038,000) $ (13,981,000)
Net loss per share attributable to common stockholders:    
Basic net loss per share attributable to common stockholders from continuing operations $ (3.17) $ (4.3)
Diluted net loss per share attributable to common stockholders from continuing operations (3.17) (4.3)
Basic net loss per share attributable to common stockholders from discontinued operations (2) (6.99)
Diluted net loss per share attributable to common stockholders from discontinued operations (2) (6.99)
Net loss per basic share attributable to common stockholders (5.17) (11.29)
Net loss per diluted share attributable to common stockholders $ (5.17) $ (11.29)
Weighted-average number of shares used in per share calculations:    
Weighted average shares - Basic 1,363,303 1,236,934
Weighted average shares - Diluted 1,363,303 1,236,934
Unrealized gains on available-for-sale securities $ 127,000 $ 101,000
Reclassification adjustment for gains on available-for-sale securities included in net loss (228,000) 0
Change in unrealized gains on available-for-sale securities (101,000) 101,000
Comprehensive loss (7,139,000) (13,880,000)
Body Care    
Operating expenses (income):    
Net loss from discontinued operations 0 (821,000)
GoodWheat    
Operating expenses (income):    
Net loss from discontinued operations (2,721,000) (7,836,000)
Product    
Revenues:    
Total revenues 5,012,000 4,437,000
License    
Revenues:    
Total revenues 7,000 17,000
Royalty    
Revenues:    
Total revenues $ 26,000 $ 0